REQUEST A DEMO
Total
USD $0.00
Search more companies

Lividus Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Lividus Pharmaceuticals Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Lividus Pharmaceuticals Private Limited is an unlisted company, incorporated on 04/08/2008. It has its registered office in the State of Kerala, India. Company's corporate identification number (CIN) is U24239KL2008PTC022904 and registration number is 022904.

Legal Address
Building No 1172 (1-5), Puthumannel Building North Pada,
Kollam; Kerala; Postal Code: 690518

Contact Details: Purchase the Lividus Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Lividus Pharmaceuticals Private Limited report to view the information.
Outstanding Shares:
Purchase the Lividus Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Lividus Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
August 04, 2008
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Lividus Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
15.49%
Total operating revenue
15.5%
Operating profit (EBIT)
5.4%
EBITDA
5.74%
Net Profit (Loss) for the Period
5.99%
Total assets
17.62%
Total equity
22.69%
Operating Profit Margin (ROS)
-0.83%
Net Profit Margin
-0.55%
Return on Equity (ROE)
-2.91%
Debt to Equity Ratio
0.87%
Quick Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?